Serotonin reuptake inhibitors in pregnancy and the risk of major malformations: a systematic review

@article{Bellantuono2007SerotoninRI,
  title={Serotonin reuptake inhibitors in pregnancy and the risk of major malformations: a systematic review},
  author={C. Bellantuono and G. Migliarese and S. Gentile},
  journal={Human Psychopharmacology: Clinical and Experimental},
  year={2007},
  volume={22}
}
  • C. Bellantuono, G. Migliarese, S. Gentile
  • Published 2007
  • Medicine
  • Human Psychopharmacology: Clinical and Experimental
  • To review studies conducted to establish the risk of major congenital malformations in women exposed to serotonin reuptake inhibitors (SRIs) during the first trimester of pregnancy. 
    35 Citations
    Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of birth defects
    • S. Gentile
    • Medicine
    • Acta psychiatrica Scandinavica
    • 2011
    • 43
    Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms
    • S. Gentile
    • Medicine
    • Expert opinion on drug metabolism & toxicology
    • 2015
    • 16
    Prenatal exposure to serotonin reuptake inhibitors: a case report
    • 5

    References

    SHOWING 1-10 OF 58 REFERENCES
    Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials.
    • 119
    Selective serotonin reuptake inhibitors and adverse pregnancy outcomes.
    • 204
    Safety of selective serotonin reuptake inhibitors in pregnancy.
    • 74
    • PDF
    Citalopram in pregnancy and lactation
    • 174